Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/186526
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPires da Rosa, Gilberto-
dc.contributor.authorSousa Pinto, Bernardo-
dc.contributor.authorFerreira, Ester-
dc.contributor.authorAraújo, Olga-
dc.contributor.authorBarilaro, Giuseppe-
dc.contributor.authorBettencourt, Paulo-
dc.contributor.authorCervera i Segura, Ricard, 1960--
dc.contributor.authorEspinosa, Gerard-
dc.date.accessioned2022-06-09T17:00:56Z-
dc.date.available2022-06-09T17:00:56Z-
dc.date.issued2022-01-03-
dc.identifier.issn1478-6362-
dc.identifier.urihttp://hdl.handle.net/2445/186526-
dc.description.abstractBackground: Seronegative antiphospholipid syndrome (SN-APS) is often defned as the presence of APS criteria manifestations, negative antiphospholipid antibodies (aPL), and coexistence of APS non-criteria manifestations. Nevertheless, the impact of these non-criteria features is still unclear. On a diferent note, the relevance of one single aPL positive determination in patients with APS manifestations is another domain with limited evidence. We aim to compare the course of SN-APS and single-positive aPL (SP-aPL) patients with that of individuals with APS manifesta‑ tions without non-criteria features/aPL positivity (controls). Methods: Retrospective analysis of patients with thrombosis/obstetric morbidity assessed in two European hospi‑ tals between 2005 and 2020. Patients were divided into SN-APS, SP-aPL, and control groups. Clinical characteristics, comorbidities, and therapies were compared. Results: A total of 82 patients were included in the SN-APS group, 88 in the SP-aPL group, and 185 in the control group. In Cox regression model, SN-APS displayed more thrombosis recurrence than controls (HR 3.8, 95% CI 2.2-6.5, p<0.001) even when adjusting for the presence of hereditary thrombophilia, systemic lupus erythematosus, or con‑ traceptive hormonal treatment. In SP-aPL, the diference in thrombosis recurrence did not reach statistical signifcance (p=0.078). Indefnite anticoagulation (p<0.001 and p=0.008, respectively) and vitamin K antagonist (VKA) use (p<0.001 in both cases) were more common in SN-APS/SP-aPL. Conclusion: SN-APS displayed more thrombosis recurrence, indefnite anticoagulation, and VKA use than controls without non-criteria manifestations. The presence of such features in patients with thrombosis and negative aPL may negatively impact their clinical course. Keywords: Antiphospholipid syndrome, Antiphospholipid antibodies, Seronegative, Single positive, Non-criteria manifestations-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s13075-021-02702-9-
dc.relation.ispartofArthritis Research & Therapy, 2022, vol. 24, num. 1, p. 9-
dc.relation.urihttps://doi.org/10.1186/s13075-021-02702-9-
dc.rightscc-by (c) Pires da Rosa, Gilberto et al., 2022-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationMalalties autoimmunitàries-
dc.subject.classificationSíndrome antifosfolipídica-
dc.subject.classificationAutoanticossos-
dc.subject.classificationLupus eritematós-
dc.subject.classificationEmbaràs-
dc.subject.otherAutoimmune diseases-
dc.subject.otherAntiphospholipid syndrome-
dc.subject.otherAutoantibodies-
dc.subject.otherLupus erythematosus-
dc.subject.otherPregnancy-
dc.titleThe presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec719910-
dc.date.updated2022-06-09T17:00:56Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina9295603-
dc.identifier.pmid34980238-
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
719910.pdf1.21 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons